| 2011 |
GATAD1 protein localizes to the nucleus of left ventricular myocytes, and a homozygous missense mutation (S102P) causes aberrant subcellular expression and nuclear morphology in cardiomyocytes, consistent with its role as a histone H3K4me3-interacting epigenetic regulator of gene expression. |
Immunohistochemistry demonstrating nuclear localization; exome sequencing and homozygosity mapping identifying pathogenic mutation; subcellular morphology analysis in patient tissue |
Circulation. Cardiovascular genetics |
Medium |
21965549
|
| 2008 |
ODAG (mouse ortholog of GATAD1) physically binds Rab6-GTPase-activating protein (Rab6-GAP) and its substrate Rab6, as identified by pull-down assay coupled with mass spectrometry; overexpression of ODAG in the mouse eye disrupts Rab6/Rab6-GAP-mediated signaling, causing elevated intraocular pressure and impaired retinal development. |
Pull-down assay combined with mass spectrometry to identify binding partners; transgenic mouse overexpression with histological and IOP phenotypic analysis |
Investigative ophthalmology & visual science |
Medium |
18791169
|
| 2016 |
Zebrafish Gatad1 protein localizes to both the nucleus and sarcomeric I-band in cardiomyocytes; gatad1 knockout zebrafish develop heart failure-like phenotypes under stress, establishing a direct role for Gatad1 in maintaining cardiac function. |
Fluorescently-tagged Gatad1 Tol2 plasmid injection for subcellular localization; TALEN-mediated knockout with longitudinal cardiac phenotyping under stress |
Journal of cardiovascular development and disease |
Medium |
28955713
|
| 2019 |
GATAD1 acts as an epigenetic chromatin topological regulator that directly promotes CCND1 transcription by inducing long-range chromatin architectural interactions at the CCND1 promoter, thereby accelerating cell cycle progression and glioblastoma cell proliferation. |
ChIP-qPCR, EMSA, chromosome conformation capture (3C), cDNA microarray, and in vivo orthotopic tumor transplantation with GATAD1 knockdown |
Cancer medicine |
High |
31286678
|
| 2023 |
GATAD1 promotes cell proliferation in ER+ breast cancer cells by transcriptionally inhibiting p21 (CDKN1A); GATAD1 depletion decreases phosphorylation of CDK2/4 and RB1, inducing G1 cell cycle arrest, and p21 overexpression abolishes the proliferative effect of GATAD1 overexpression. |
CRISPR synthetic lethality screen, siRNA knockdown, overexpression, cell cycle analysis, western blotting for CDK2/4 and RB1 phosphorylation, p21 rescue experiment |
Medical oncology |
Medium |
37567972
|
| 2022 |
GATAD1 transcriptionally activates SRRM2 expression in thyroid carcinoma cells; GATAD1-induced cell proliferation is dependent on increased SRRM2 expression, as SRRM2 knockdown abolishes GATAD1-driven proliferation. |
Knockdown and overexpression of GATAD1 with measurement of SRRM2 mRNA/protein levels; epistasis via SRRM2 knockdown rescue experiment; cell proliferation and cell cycle assays |
Gland surgery |
Medium |
36654960
|
| 2024 |
GATAD1 acts as a transcription factor in cardiomyocytes to inhibit fatty acid oxidation genes (Acaa2, Acadm) and promote glucose oxidation gene expression (Pdha1); cardiomyocyte-specific Gatad1 knockout worsens ischemia-reperfusion injury and abolishes SPC-mediated cardioprotection, while GATAD1 nuclear localization is regulated by sphingosylphosphorylcholine (SPC). |
Cardiomyocyte-specific conditional knockout mice, immunofluorescence and nuclear-cytoplasmic fractionation for localization, dual luciferase reporter assay, qPCR, siRNA/overexpression of downstream targets, in vivo I/R injury model |
Free radical biology & medicine |
High |
39626862
|
| 2024 |
Cardiomyocyte-specific deletion of Gatad1 in mice does not cause cardiomyopathy during aging up to 18 months or under pressure overload (TAC), and does not alter cardiomyocyte nuclear morphology, suggesting GATAD1 is not cell-autonomously required in murine cardiomyocytes for cardiac structural maintenance. |
Cardiomyocyte-specific Gatad1 cKO mouse model; cardiac function monitored longitudinally; TAC pressure overload stress model; nuclear morphology analysis |
Journal of molecular histology |
Medium |
39641830
|
| 2025 |
GATAD1 regulates blood-brain barrier permeability in ischemic stroke by transcriptionally controlling CD36 expression in cerebral endothelial cells, thereby modulating caveolae-mediated transcytosis; endothelial-specific Gatad1 deletion reduces infarct volume and BBB dysfunction after experimental stroke. |
Endothelial cell-specific Gatad1 knockout mice; experimental ischemic stroke model; measurement of infarct volume and BBB permeability; mechanistic analysis of CD36 expression and caveolae-mediated transcytosis |
Neuroscience bulletin |
Medium |
40965809
|